Multiple Myeloma and IV Bisphosphonate Are Risk Factors for Osteonecrosis of the Jaw

被引：0
|
作者：
Tennis, Pat [1 ]
Rothman, Kenneth J. [1 ]
Bohn, Rhonda [2 ]
Tan, Hiangkat [2 ]
Anthony, Mary [3 ]
Zavras, Athanosios [4 ]
Calingaert, Brian [1 ]
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] Healthcore Inc, Wilmington, DE USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
[4] Columbia Univ, New York, NY USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
741
引用
收藏
页码：S313 / S314
页数：2
相关论文
共 50 条
  • [31] Osteonecrosis of the Jaw in Multiple Myeloma Patients: Risk Factors of Early ONJ, Decreased Impact After 2005
    Fuzibet, J. G.
    Rossignol, B.
    Vieillard, M. H.
    Fontas, E.
    Hulin, C.
    Vekemans, M. C.
    Garderet, L.
    Marevoet, M.
    Blanc, M.
    Azais, I.
    Marit, G.
    Facon, T.
    Moreau, P.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S19 - S20
  • [32] Bisphosphonate Exposure and Osteonecrosis of the Jaw
    Borromeo, Gelsomina L.
    Brand, Caroline
    Clement, John G.
    McCullough, Michael
    Crighton, Lisa
    Hepworth, Graham
    Wark, John D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2015, 30 (04) : 749 - 750
  • [33] Bisphosphonate-related osteonecrosis of the jaw in a multiple myeloma patient: A case report with characteristic radiographic features
    Lee, Byung-Do
    Park, Moo-Rim
    Kwon, Kyung-Hwan
    IMAGING SCIENCE IN DENTISTRY, 2015, 45 (03) : 199 - 203
  • [34] Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment
    Dickinson, M.
    Prince, H. M.
    Kirsa, S.
    Zannettino, A.
    Gibbs, S. D. J.
    Mileshkin, L.
    O'Grady, J.
    Seymour, J. F.
    Szer, J.
    Horvath, N.
    Joshua, D. E.
    INTERNAL MEDICINE JOURNAL, 2009, 39 (05) : 304 - 316
  • [35] Database analysis of the risk factors of bisphosphonate-related osteonecrosis of the jaw in Hungarian patients
    Kotan, Edit Veszelyne
    Bartha-Lieb, Timea
    Parisek, Zsolt
    Mesko, Attilane
    Vaszilko, Mihaly
    Hanko, Balazs
    BMJ OPEN, 2019, 9 (05):
  • [36] Bisphosphonate-Induced Osteonecrosis of the Jaw 32 Months After Interruption of Zoledronate in a Patient With Multiple Myeloma
    Del Conte, Alessandro
    Bernardeschi, Paolo
    La Ferla, Fabio
    Turrisi, Gina
    D'Alessandro, Michelina
    Montagnani, Francesco
    Fiorentini, Giammaria
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2010, 68 (05) : 1179 - 1182
  • [37] Bisphosphonate-induced osteonecrosis of the jaw: Risk factors and diagnostic utility of bone scans
    O'Connor, T. L.
    Padmanabhan, A.
    Wilding, G.
    Sullivan, M.
    Solomon, L.
    Lamonica, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Bisphosphonate' Associated Osteonecrosis of the Jaw
    Ben Abdelghani, Kaouther
    Dhahri, Rim
    Souabni, Leila
    Kassab, Selma
    Chkili, Selma
    Laatar, Ahmed
    Zakraoui, Leith
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S88 - S88
  • [39] Bisphosphonate Induced Osteonecrosis of the Jaw (BONJ) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
    Oduncu, Fuat
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E77 - E78
  • [40] Reduced bisphosphonate schedule may decrease jaw osteonecrosis risk
    Reactions Weekly, 2007, 1135 (1) : 1 - 1
12345